Patent · US Active

Stable liquid formulation of AMG 416 (etelcalcetide)

US11162500B2 · kind B2 · utility

0Cited by
10References
88Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 3, 2019
Grant dateNov 2, 2021
Priority date
Expiry dateJun 3, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A liquid formulation comprising a peptide agonist of the calcium sensing receptor and method of preparing and using the formulation are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.